Parexel on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley gave Parexel International Corp. a hold rating after the company reported first-quarter 2007 earnings of $0.25 on $165.1 million in revenue compared to the analyst's estimate of $0.24 on $163.3 million and consensus of $0.24 on $166.9 million. Management raised its earnings per share guidance by 2 cents the range of $1.16 to $1.26 while cutting revenue guidance by about $8 million. Shares of the Waltham, Mass.-based biopharmaceutical company were down $4.24, or 12.66%, at $29.25. (Nasdaq: PRXL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.